Empirical Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
APM
HIIFS
Empirical Wealth Management's XBI Position: Q2 2022 in Review
Empirical Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 2,330 shares — an estimated $209K sold.
Empirical Wealth Management first reported a position in XBI in Q4 2021 and held it in 2 quarters. The position peaked at $261K in Q4 2021. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.
- Empirical Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
- Empirical Wealth Management sold 2,330 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $209K.
- Empirical Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 2 quarters.
- Empirical Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $261K in Q4 2021.
- 706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.
Based on Empirical Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.